MA32810B1 - Ester de diol et d'acide gras polyinsature comme agent anti-acne - Google Patents

Ester de diol et d'acide gras polyinsature comme agent anti-acne

Info

Publication number
MA32810B1
MA32810B1 MA33865A MA33865A MA32810B1 MA 32810 B1 MA32810 B1 MA 32810B1 MA 33865 A MA33865 A MA 33865A MA 33865 A MA33865 A MA 33865A MA 32810 B1 MA32810 B1 MA 32810B1
Authority
MA
Morocco
Prior art keywords
diole
ester
fatty acids
unsaturated fatty
acne
Prior art date
Application number
MA33865A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Daniel Redoules
Sylvie Daunes-Marion
Marie-Françoise Aries
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32810(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MA32810B1 publication Critical patent/MA32810B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA33865A 2008-12-22 2011-05-20 Ester de diol et d'acide gras polyinsature comme agent anti-acne MA32810B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0858967A FR2940281B1 (fr) 2008-12-22 2008-12-22 Ester de diol et d'acide gras polyinsature comme agent anti-acne
PCT/EP2009/067701 WO2010072738A1 (fr) 2008-12-22 2009-12-21 Ester de diol et d'acide gras polyinsature comme agent anti-acne

Publications (1)

Publication Number Publication Date
MA32810B1 true MA32810B1 (fr) 2011-11-01

Family

ID=40875013

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33865A MA32810B1 (fr) 2008-12-22 2011-05-20 Ester de diol et d'acide gras polyinsature comme agent anti-acne

Country Status (26)

Country Link
US (1) US8623916B2 (enExample)
EP (1) EP2379484B1 (enExample)
JP (1) JP5587333B2 (enExample)
KR (1) KR101676055B1 (enExample)
CN (1) CN102256930B (enExample)
AU (1) AU2009331526B2 (enExample)
BR (1) BRPI0923494B1 (enExample)
CA (1) CA2747681C (enExample)
CL (1) CL2011001539A1 (enExample)
CO (1) CO6390033A2 (enExample)
ES (1) ES2424088T3 (enExample)
FR (1) FR2940281B1 (enExample)
GE (1) GEP20135820B (enExample)
IL (1) IL213646A (enExample)
MA (1) MA32810B1 (enExample)
MX (1) MX2011006659A (enExample)
MY (1) MY151002A (enExample)
NZ (1) NZ593781A (enExample)
PL (1) PL2379484T3 (enExample)
PT (1) PT2379484E (enExample)
RU (1) RU2524779C2 (enExample)
SG (1) SG172342A1 (enExample)
TN (1) TN2011000237A1 (enExample)
UA (1) UA103645C2 (enExample)
WO (1) WO2010072738A1 (enExample)
ZA (1) ZA201103509B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6336902B2 (ja) * 2011-06-22 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド コンジュゲートベースの抗真菌性および抗菌性プロドラッグ
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CA2920457A1 (en) * 2013-08-08 2015-02-12 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
FR3033135B1 (fr) * 2015-02-27 2018-03-16 Pierre Fabre Dermo-Cosmetique Association d'un retinoide et d'un ester de diol et d'acide gras polyinsature
FR3053253B1 (fr) * 2016-07-01 2020-01-17 Pierre Fabre Dermo-Cosmetique Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5534762B2 (enExample) 1975-02-07 1980-09-09
DE4240674C2 (de) 1992-11-26 1999-06-24 Schuelke & Mayr Gmbh Desodorierende Wirkstoffe
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH09110818A (ja) * 1995-10-16 1997-04-28 Sanshin Chem Ind Co Ltd 1−エチル−3−(3−ジメチルアミノプロピル)カルボジイミド塩酸塩の製造方法
ES2176692T3 (es) 1996-02-21 2002-12-01 Stoa Sa Composiciones cosmeticas, dermofarmaceuticas o veterinarias para el tratamiento aseptico de la piel humana o animal.
GB9620248D0 (en) * 1996-09-26 1996-11-13 Scotia Holdings Plc Esters of unsaturated fatty acids
GB9622636D0 (en) 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO2001001980A1 (en) * 1999-07-06 2001-01-11 The Regents Of The University Of California Methods for the amelioration of neuropsychiatric disorders by inhibiting the inactivating transport of endogenous cannabinoid substances
GB9927629D0 (en) * 1999-11-24 2000-01-19 Croda Int Plc Compounds
ES2208498T3 (es) 2001-06-22 2004-06-16 SYMRISE GMBH & CO. KG Uso de 1,2-decanodiol contra germenes causantes de olores corporales desagradables.
US20070265352A1 (en) 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
DE10206759A1 (de) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
SE0301862D0 (sv) 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
DE102004031210A1 (de) * 2004-06-28 2006-02-09 Trommsdorff Gmbh & Co. Kg MLV-Kosmetikum
DE10341179A1 (de) 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
US7935732B2 (en) 2004-04-08 2011-05-03 Isp Investments Inc. Antimicrobial compositions
ES2352744T3 (es) * 2004-04-27 2011-02-22 Akzo Nobel Coatings International Bv Pintura pigmentada que se desprende a tiras.
JP2006056795A (ja) * 2004-08-18 2006-03-02 Suntory Ltd 6−o−pufaアスコルビン酸エステルを含有する皮膚化粧料並びに飲食品
DE102006044849A1 (de) * 2006-09-22 2008-04-03 Symrise Gmbh & Co. Kg Dekonjugierte Alkadiensäureester als Riech- und/oder Aromastoffe

Also Published As

Publication number Publication date
FR2940281B1 (fr) 2011-04-01
RU2524779C2 (ru) 2014-08-10
UA103645C2 (uk) 2013-11-11
CA2747681A1 (fr) 2010-07-01
EP2379484B1 (fr) 2013-05-29
ES2424088T3 (es) 2013-09-27
JP5587333B2 (ja) 2014-09-10
FR2940281A1 (fr) 2010-06-25
ZA201103509B (en) 2012-01-25
TN2011000237A1 (fr) 2012-12-17
IL213646A0 (en) 2011-07-31
SG172342A1 (en) 2011-07-28
KR20110101152A (ko) 2011-09-15
IL213646A (en) 2014-03-31
CO6390033A2 (es) 2012-02-29
WO2010072738A1 (fr) 2010-07-01
BRPI0923494A2 (pt) 2016-01-26
CN102256930B (zh) 2014-03-12
PT2379484E (pt) 2013-08-22
CA2747681C (fr) 2017-05-16
RU2011128264A (ru) 2013-01-27
MY151002A (en) 2014-03-31
GEP20135820B (en) 2013-05-10
HK1163655A1 (en) 2012-09-14
KR101676055B1 (ko) 2016-11-14
NZ593781A (en) 2013-02-22
JP2012513380A (ja) 2012-06-14
PL2379484T3 (pl) 2013-10-31
CN102256930A (zh) 2011-11-23
US8623916B2 (en) 2014-01-07
BRPI0923494B1 (pt) 2017-04-18
AU2009331526A1 (en) 2010-07-01
AU2009331526B2 (en) 2013-10-24
EP2379484A1 (fr) 2011-10-26
US20110230557A1 (en) 2011-09-22
MX2011006659A (es) 2011-07-12
CL2011001539A1 (es) 2011-10-14

Similar Documents

Publication Publication Date Title
MA38099A1 (fr) Des nouveaux composes triazolopyrazines substitues inhibiteurs des brd4
MA32810B1 (fr) Ester de diol et d'acide gras polyinsature comme agent anti-acne
MA38227B1 (fr) Nouveaux composés bicycliques et leur utilisation en tant qu'agents antibactériens et inhibiteurs de ß-lactamase
MA32035B1 (fr) Composes tricycliques servant de modulateurs de synthese de tnf-alpha et d'inhibiteurs de pde4
MA31841B1 (fr) Modulateurs du gpr40 à biphényle substitué
MA35039B1 (fr) Dérivés ramifiés de l'acide 3-phénylpropionique et leur utilisation
MA42231B1 (fr) Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant
TN2009000138A1 (fr) Biaryl-ether-urees
EP2823819A4 (en) PHARMACEUTICAL COMPOSITION USING OLEANOLIC ACIDATE AS ACTIVE AGENT FOR PREVENTING OR TREATING TLR OR IL-6 MEDIATED DISEASES
MA32471B1 (fr) Composés de borates esters et compositions pharmaceutiques contenant des composés
MA37762B1 (fr) Composés n-aryltriazole utilisés comme antagonistes de lpar
MA37764A1 (fr) Composés n-alkyltriazole utilisés comme antagonistes de lpar
MA33467B1 (fr) Promédicaments comprenant un conjugué insuline-lieur
FR2939135B1 (fr) Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
MA31296B1 (fr) Derives d'imidazolidine carboxamide en tant qu'inhibiteurs de lipase et de phospholipase
MA31094B1 (fr) Utilisation de dérivés de pyranone-acide substituée pour le traitement du syndrome métabolique
MA35411B1 (fr) Nouvelle composition thérapeutique contenant de l'apomorphine comme principe actif
FR2970971B1 (fr) Utilisation d'au moins un co-produit de l'industrie du raffinage des huiles vegetales pour obtenir un insaponifiable total purifie d'huile vegetale.
MA34724B1 (fr) Nouvelle forme d'administration d'un inhibiteur de l'enképhalinase
MA41494A (fr) Composés benzoxaborole substitués en position 4 et utilisations associées
FR2952372B1 (fr) Nouveaux derives de mannopyranoside ayant une activite anticancereuse
MA20150297A1 (fr) Composition de traitement de minerais de phosphate
FR2869611A1 (fr) Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
MA39750B1 (fr) Dérivés d'acide aza-indol-acétique et leur utilisation comme modulateurs des récepteurs de la prostaglandine d2
MA35102B1 (fr) Dérivés d'acide 7-(hétéroaryl-amino)-6,7,8,9-tétrahydropyrido[1,2-a]indolacétique et leur utilisation en tant que modulateurs du récepteur aux prostaglandines d2